SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
SiriusPoint Ltd. (SPNT-PB) trades at a trailing P/E of 7.0, forward P/E of 10.2. Trailing earnings yield is 14.33%, forward earnings yield 9.85%. PEG 0.04 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (7.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.04); earnings yield beats bond yields (14.33%).
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 14.33% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 75/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SPNT-PB
Valuation Multiples
P/E (TTM)7.0
Forward P/E10.2
PEG Ratio0.04
Forward PEG0.91
P/B Ratio0.00
P/S Ratio0.97
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.65
Forward EPS (Est.)$2.51
Book Value / Share$0.00
Revenue / Share$26.35
FCF / Share$0.00
Yields & Fair Value
Earnings Yield14.33%
Forward Earnings Yield9.85%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.26 |
$708.54M |
$27.64M |
3.9% |
| 2017 |
$2.64 |
$926.71M |
$277.8M |
30% |
| 2018 |
$-3.27 |
$377.51M |
$-317.69M |
-84.2% |
| 2019 |
$2.16 |
$979.07M |
$200.62M |
20.5% |
| 2020 |
$1.53 |
$884.57M |
$143.8M |
16.3% |
| 2021 |
$0.27 |
$2.22B |
$58.1M |
2.6% |
| 2022 |
$-2.41 |
$66M |
$-386M |
-584.8% |
| 2023 |
$1.85 |
$2.74B |
$354.8M |
13% |
| 2024 |
$1.29 |
$2.6B |
$199.9M |
7.7% |
| 2025 |
$3.65 |
$3.21B |
$459.6M |
14.3% |
